Tratamiento de la enfermedad de Wilson durante el embarazo. Primer caso reportado en Cuba.
Abstract
La enfermedad de Wilson o degeneración hepatolenticular, es un trastorno del metabolismo del cobre que se hereda de forma autosómica recesiva; su incidencia a nivel global es de 1 de cada 30.000 habitantes. Se presenta el primer caso en Cuba de una gestante con diagnóstico de enfermedad de Wilson atendida en la consulta integral para embarazadas del Policlínico Comunitario Docente Sur de Ciego de Ávila; se describe el tratamiento que se debe realizar en estas pacientes.
Downloads
References
Solís Muñoz P, Solís Herruzo JA. Wilson's disease, a rare thought present condition. Rev Esp Enferm Dig [Internet]. 2008 [citado 10 Mar 2010]; 100(8): [aprox. 7 p.]. Disponible en: http://scielo.isciii.es/scielo.php?pid=S1130-01082008000800001&script=sci_arttext
Barber MA, Eguiluz I, Plasencia W, Ramírez O. Enfermedad de Wilson y gestación. Clin Invest Gin Obst. 2003; 30(10):328-32.
Moreno Plana JM, Broseta Viana L, Herrero Quiroz C, Calvo Mayo JM, García Ramos M, Pérez Flores R. Enfermedad de Wilson y embarazo. Rev Esp Enferm Dig. 2002; 94 (4): 226-232.
Tarnacka B, Rodo M, Cichy S, Czlonkowska A. Procreation ability in Wilson's disease. Act Neurol Scand. 2000; 101: 395-8.
Foruny Olcina JR, Boixeda de Miquel D. Enfermedad de Wilson. Rev Esp Enferm Dig [Internet]. 2010 [citado 2012 Abr 15]; 102(1): 53-54. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082010000100009&lng=es
Beers MH, Porter RS, Jones TV, Kaplan JL, Berkwits M. El Manual Merck de diagnóstico y terapéutica [Internet]. 1 ed. Madrid: Elsevier; 2007. Disponible en: http://www.epgonline.org/mobile/drugdetails.cfm/id/DR006781/page/atoz/letter/W/language/LG0004/startrow_drug/1/drugName/Wilzin-c%C3%A1psulas-duras.
Downloads
Published
How to Cite
Issue
Section
License
MediCiego does not apply publication charges. The journal is available in open access without restrictions, in compliance with the international policy on open access to information for the exchange of global knowledge.
The authors will retain their copyright and guarantee the journal the right of first publication of their work. MediCiego is licensed under the Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/deed.es_ES), so it is allowed to copy, reproduce, distribute, publicly communicate the work and generate derivative works, as long as the original author is cited and acknowledged. However, it is not allowed to use the original work for commercial or lucrative purposes.
Authors must sign a copyright agreement through an affidavit of authorship and originality, before publishing.
The authors authorize the publication of their writings; they retain the copyright, and assign to the journal all the rights protected by the Copyright Law that governs Cuba, and implies the edition to disseminate the work.
Likewise, they may establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with the recognition of having been first published in this journal.
Declaration of authorship: download here the Affidavit
